Plain-English translation of NCT07234968 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When bladder cancer requires removal of the entire bladder, surgeons must also reconnect the tubes (ureters) that normally drain urine from the kidneys to a surgically created pouch. This trial is testing whether using temporary protective tubes called ureteral stents during this surgery makes a difference in how well patients recover. The study will compare outcomes in patients who receive stents versus those who do not, following both groups for one year after surgery.
Surgeons currently use both approaches—with and without stents—as acceptable standard care, but it's unclear which one actually leads to fewer complications and better patient outcomes. This trial will provide clear evidence to help guide the best surgical approach for bladder cancer patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo bladder removal surgery at Thomas Jefferson University. Before surgery, you will be randomly assigned to either receive ureteral stents (which will be removed 1–3 weeks after surgery) or to have surgery without stents. After surgery, you will attend follow-up visits at 30 days, 3 months, 6 months, and 12 months to check your recovery and watch for any complications. The study team will monitor your surgical outcomes, healing, and any problems that arise during this one-year period.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States